Published in Eur J Nucl Med Mol Imaging on September 29, 2012
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol (2016) 1.32
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET. Eur J Nucl Med Mol Imaging (2014) 1.26
Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma. J Clin Oncol (2015) 1.06
Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors. Mol Imaging (2014) 1.04
Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis. Neuro Oncol (2015) 1.04
From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors? Neuro Oncol (2015) 0.99
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate. Clin Cancer Res (2015) 0.96
Increased tryptophan uptake on PET has strong independent prognostic value in patients with a previously treated high-grade glioma. Neuro Oncol (2014) 0.93
Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients. Neuro Oncol (2014) 0.88
Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [(18)F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience. Eur J Nucl Med Mol Imaging (2015) 0.87
The use of longitudinal 18F-FET MicroPET imaging to evaluate response to irinotecan in orthotopic human glioblastoma multiforme xenografts. PLoS One (2014) 0.87
Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy. Clin Cancer Res (2014) 0.85
Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI. Eur J Nucl Med Mol Imaging (2015) 0.83
18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastoma. PLoS One (2015) 0.81
The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients. Cancer Manag Res (2014) 0.81
Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging. J Nucl Med (2015) 0.80
Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance? Oncotarget (2016) 0.78
ASYMMETRIC CELL DIVISION: IMPLICATIONS FOR GLIOMA DEVELOPMENT AND TREATMENT. Transl Neurosci (2013) 0.77
Towards standardization of (18)F-FET PET imaging: do we need a consistent method of background activity assessment? EJNMMI Res (2017) 0.77
Amino Acid PET - An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence? Front Neurol (2016) 0.76
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy. Neuroimage Clin (2016) 0.76
Patient outcome in the Belgian medical need program on bevacizumab for recurrent glioblastoma. J Neurol (2015) 0.76
Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches. Front Neurosci (2016) 0.75
Improving contrast enhancement in magnetic resonance imaging using 5-aminolevulinic acid-induced protoporphyrin IX for high-grade gliomas. Oncol Lett (2016) 0.75
Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers. Eur J Nucl Med Mol Imaging (2016) 0.75
Synthesis and biological evaluation of O-[3-18F-fluoropropyl]-α-methyl tyrosine in mesothelioma-bearing rodents. Biomed Res Int (2013) 0.75
Follow-Up Imaging: Molecular Imaging is Likely Best as a Single Modality, but Multimodality Imaging is the Future. Front Neurol (2015) 0.75
Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment. PLoS One (2016) 0.75
[Molecular imaging in neurological diseases]. Radiologe (2016) 0.75
Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI: a feasibility study. Eur J Nucl Med Mol Imaging (2017) 0.75
Amino acid PET and MR perfusion imaging in brain tumours. Clin Transl Imaging (2017) 0.75
Comparison of (18)F-FET PET and perfusion-weighted MRI for glioma grading: a hybrid PET/MR study. Eur J Nucl Med Mol Imaging (2017) 0.75
Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine. Biomedicines (2016) 0.75
Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective. Clin Transl Imaging (2016) 0.75
PET/MRI: Where might it replace PET/CT? J Magn Reson Imaging (2017) 0.75
Evaluation of factors influencing (18)F-FET uptake in the brain. Neuroimage Clin (2017) 0.75
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55
Angiogenesis in cancer and other diseases. Nature (2000) 28.28
Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol (1990) 18.71
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol (2010) 14.79
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol (2007) 12.62
Molecular regulation of vessel maturation. Nat Med (2003) 11.74
Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion. Cancer Res (2011) 2.40
O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain (2005) 2.37
Bevacizumab has differential and dose-dependent effects on glioma blood vessels and tumor cells. Clin Cancer Res (2011) 2.06
FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading. Eur J Nucl Med Mol Imaging (2007) 1.47
One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma. Neurology (2004) 1.36
Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas. Neuro Oncol (2011) 1.35
Advances in MRI assessment of gliomas and response to anti-VEGF therapy. Curr Neurol Neurosci Rep (2011) 1.34
Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J Nucl Med (2006) 1.33
O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma. J Nucl Med (2011) 1.30
Rechallenge with temozolomide in patients with recurrent gliomas. J Neurol (2009) 1.24
Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol. Cancer (2010) 1.20
O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging (2005) 1.20
"Facilitated" amino acid transport is upregulated in brain tumors. J Cereb Blood Flow Metab (1998) 1.15
Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med (1999) 1.14
O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma. Eur J Nucl Med Mol Imaging (2005) 1.14
Polarization of tumor-associated macrophages: a novel strategy for vascular normalization and antitumor immunity. Cancer Cell (2011) 1.10
Patterns of progression in malignant glioma following anti-VEGF therapy: perceptions and evidence. Curr Neurol Neurosci Rep (2011) 1.07
Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas. Eur J Nucl Med Mol Imaging (2010) 1.06
Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI. J Nucl Med (2012) 1.05
Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2010) 1.03
Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme. Eur J Nucl Med Mol Imaging (2010) 1.03
Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. Eur J Nucl Med Mol Imaging (2006) 1.03
Efficient routine production of the 18F-labelled amino acid O-2-18F fluoroethyl-L-tyrosine. Appl Radiat Isot (2002) 0.98
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy. Clin Nucl Med (2011) 0.95
Serial O-(2-[(18)F]fluoroethyl)-L: -tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma. Eur J Nucl Med Mol Imaging (2006) 0.90
Patient-tailored, imaging-guided, long-term temozolomide chemotherapy in patients with glioblastoma. Mol Imaging (2010) 0.89
Quantitation of angiogenesis and its correlation with vascular endothelial growth factor expression in astrocytic tumors. Anal Quant Cytol Histol (2004) 0.87
Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report. J Neurooncol (2007) 0.85
A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage (2005) 13.40
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol (2012) 6.20
Long-term survival with glioblastoma multiforme. Brain (2007) 4.51
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol (2009) 4.32
Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma. J Nucl Med (2012) 3.67
The functional organization of the intraparietal sulcus in humans and monkeys. J Anat (2005) 3.24
An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol (2009) 3.15
Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. J Neurosci (2008) 2.75
Intraoperative frozen section analysis of margins in breast conserving surgery significantly decreases reoperative rates: one-year experience at an ambulatory surgical center. Am J Clin Pathol (2012) 2.73
Neural circuits underlying imitation learning of hand actions: an event-related fMRI study. Neuron (2004) 2.73
Lateralized cognitive processes and lateralized task control in the human brain. Science (2003) 2.62
Neural signatures of body ownership: a sensory network for bodily self-consciousness. Cereb Cortex (2006) 2.51
Nucleophilic 18F-fluorination of heteroaromatic iodonium salts with no-carrier-added [18F]fluoride. J Am Chem Soc (2007) 2.41
Cortical connectivity after subcortical stroke assessed with functional magnetic resonance imaging. Ann Neurol (2008) 2.38
O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain (2005) 2.37
Combined MRI-PET dissects dynamic changes in plant structures and functions. Plant J (2009) 2.32
Minds at rest? Social cognition as the default mode of cognizing and its putative relationship to the "default system" of the brain. Conscious Cogn (2008) 2.30
Being with virtual others: Neural correlates of social interaction. Neuropsychologia (2005) 2.14
BigBrain: an ultrahigh-resolution 3D human brain model. Science (2013) 2.12
Analysis of neural mechanisms underlying verbal fluency in cytoarchitectonically defined stereotaxic space--the roles of Brodmann areas 44 and 45. Neuroimage (2004) 2.10
Sex differences and the impact of steroid hormones on the developing human brain. Cereb Cortex (2008) 1.90
Reorganization of cerebral networks after stroke: new insights from neuroimaging with connectivity approaches. Brain (2011) 1.89
Minds made for sharing: initiating joint attention recruits reward-related neurocircuitry. J Cogn Neurosci (2010) 1.89
Mirror neuron and theory of mind mechanisms involved in face-to-face interactions: a functional magnetic resonance imaging approach to empathy. J Cogn Neurosci (2007) 1.88
Gender differences in brain networks supporting empathy. Neuroimage (2008) 1.84
Interhemispheric integration of visual processing during task-driven lateralization. J Neurosci (2007) 1.78
O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol (2006) 1.77
Using fMRI to decompose the neural processes underlying the Wisconsin Card Sorting Test. Neuroimage (2006) 1.77
Differential remoteness and emotional tone modulate the neural correlates of autobiographical memory. Brain (2003) 1.77
Intrinsic network connectivity reflects consistency of synesthetic experiences. J Neurosci (2012) 1.70
Dynamic intra- and interhemispheric interactions during unilateral and bilateral hand movements assessed with fMRI and DCM. Neuroimage (2008) 1.69
Development of attentional networks: an fMRI study with children and adults. Neuroimage (2005) 1.62
Cerebral correlates of alerting, orienting and reorienting of visuospatial attention: an event-related fMRI study. Neuroimage (2004) 1.62
Cytoarchitectonic identification and probabilistic mapping of two distinct areas within the anterior ventral bank of the human intraparietal sulcus. J Comp Neurol (2006) 1.61
Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival. Clin Cancer Res (2009) 1.61
Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU. Eur J Nucl Med Mol Imaging (2008) 1.58
Interhemispheric competition after stroke: brain stimulation to enhance recovery of function of the affected hand. Neurorehabil Neural Repair (2009) 1.56
Essential tremor and tremor in Parkinson's disease are associated with distinct 'tremor clusters' in the ventral thalamus. Exp Neurol (2012) 1.55
The role of the contralesional motor cortex for motor recovery in the early days after stroke assessed with longitudinal FMRI. Cereb Cortex (2010) 1.54
Prefrontal involvement in imitation learning of hand actions: effects of practice and expertise. Neuroimage (2007) 1.53
Malignant deep brain stimulation-withdrawal syndrome in a patient with Parkinson's disease. Mov Disord (2013) 1.51
Modulating cortical connectivity in stroke patients by rTMS assessed with fMRI and dynamic causal modeling. Neuroimage (2009) 1.51
Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide. J Clin Oncol (2012) 1.51
Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma. Ann Neurol (2003) 1.50
Effects of low-frequency repetitive transcranial magnetic stimulation of the contralesional primary motor cortex on movement kinematics and neural activity in subcortical stroke. Arch Neurol (2008) 1.49
Yearning to yawn: the neural basis of contagious yawning. Neuroimage (2005) 1.49
It's in your eyes--using gaze-contingent stimuli to create truly interactive paradigms for social cognitive and affective neuroscience. Soc Cogn Affect Neurosci (2010) 1.49
Activation likelihood estimation meta-analysis of motor-related neural activity after stroke. Neuroimage (2011) 1.48
Enhancing language performance with non-invasive brain stimulation--a transcranial direct current stimulation study in healthy humans. Neuropsychologia (2007) 1.46
Comparison of (18)F-FET and (18)F-FDG PET in brain tumors. Nucl Med Biol (2009) 1.46
Morphometric brain abnormalities in boys with conduct disorder. J Am Acad Child Adolesc Psychiatry (2008) 1.46
Human medial intraparietal cortex subserves visuomotor coordinate transformation. Neuroimage (2004) 1.45
Neurophysiological correlates of relatively enhanced local visual search in autistic adolescents. Neuroimage (2007) 1.45
Clinical outcome of subthalamic stimulation in Parkinson's disease is improved by intraoperative multiple trajectories microelectrode recording. J Neurol Surg A Cent Eur Neurosurg (2012) 1.42
Crossmodal processing of object features in human anterior intraparietal cortex: an fMRI study implies equivalencies between humans and monkeys. Neuron (2002) 1.42
Sensorimotor processing in the grip-lift task: the impact of maximum wrist flexion/extension on force scaling. Clin Neurophysiol (2009) 1.41
Dysfunctional attentional networks in children with attention deficit/hyperactivity disorder: evidence from an event-related functional magnetic resonance imaging study. Biol Psychiatry (2005) 1.40
Nicotine modulates reorienting of visuospatial attention and neural activity in human parietal cortex. Neuropsychopharmacology (2005) 1.39
Dorsal and ventral attention systems: distinct neural circuits but collaborative roles. Neuroscientist (2013) 1.38
The somatotopic organization of cytoarchitectonic areas on the human parietal operculum. Cereb Cortex (2006) 1.37
Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study. J Neurosci (2007) 1.37
Transcranial magnetic stimulation and the challenge of coil placement: a comparison of conventional and stereotaxic neuronavigational strategies. Hum Brain Mapp (2008) 1.37
Probabilistic fibre tract analysis of cytoarchitectonically defined human inferior parietal lobule areas reveals similarities to macaques. Neuroimage (2011) 1.36
Structural brain abnormalities in adolescents with autism spectrum disorder and patients with attention deficit/hyperactivity disorder. J Child Psychol Psychiatry (2007) 1.36
Gender differences in the functional neuroanatomy of emotional episodic autobiographical memory. Hum Brain Mapp (2005) 1.35
Neural representations of self versus other: visual-spatial perspective taking and agency in a virtual ball-tossing game. J Cogn Neurosci (2006) 1.32
Cortical representations of personally familiar objects and places: functional organization of the human posterior cingulate cortex. J Cogn Neurosci (2005) 1.32
Cue validity modulates the neural correlates of covert endogenous orienting of attention in parietal and frontal cortex. Neuroimage (2006) 1.31
Disentangling self- and fairness-related neural mechanisms involved in the ultimatum game: an fMRI study. Soc Cogn Affect Neurosci (2012) 1.30
Reward system dysfunction in autism spectrum disorders. Soc Cogn Affect Neurosci (2012) 1.30
Akinetic-rigid and tremor-dominant Parkinson's disease patients show different patterns of FP-CIT single photon emission computed tomography. Mov Disord (2011) 1.29
Performing allocentric visuospatial judgments with induced distortion of the egocentric reference frame: an fMRI study with clinical implications. Neuroimage (2003) 1.28
FDG--a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer. Eur J Nucl Med Mol Imaging (2006) 1.27
Differential effects of high-frequency repetitive transcranial magnetic stimulation over ipsilesional primary motor cortex in cortical and subcortical middle cerebral artery stroke. Ann Neurol (2009) 1.26
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET. Eur J Nucl Med Mol Imaging (2014) 1.26
Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis. J Nucl Med (2012) 1.25
Deformation field morphometry reveals age-related structural differences between the brains of adults up to 51 years. J Neurosci (2008) 1.25
Fear processing and social networking in the absence of a functional amygdala. Biol Psychiatry (2012) 1.23
18F-FET PET differentiation of ring-enhancing brain lesions. J Nucl Med (2006) 1.22